COMBINED TREATMENT WITH RADIATION AND AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
摘要
The present invention provides a method for manufacturing a medicament intended for treating tumors or tumor metastases in a patient, characterized in that a therapeutically effective amount of an EGFR kinase inhibitor and ionizing radiation is used, with or without additional agents or treatments, such as other anti-cancer drugs. A preferred example of an EGFR kinase inhibitor that can be used in practicing this invention is the compound erlotinib HCI (also known as Tarceva <SUP>TM</SUP>).
申请公布号
WO2006110176(A2)
申请公布日期
2006.10.19
申请号
WO2005US37325
申请日期
2005.10.18
申请人
HARARI, PAUL, M.;CHINNAIYAN, PRAKASH;HUANG, SHYMIN JASON
发明人
HARARI, PAUL, M.;CHINNAIYAN, PRAKASH;HUANG, SHYMIN JASON